z-logo
Premium
Late‐onset myasthenia not on the increase: a nationwide register study in D enmark, 1996–2009
Author(s) -
Pedersen E. G.,
Hallas J.,
Hansen K.,
Jensen P. E. H.,
Gaist D.
Publication year - 2013
Publication title -
european journal of neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.881
H-Index - 124
eISSN - 1468-1331
pISSN - 1351-5101
DOI - 10.1111/j.1468-1331.2012.03850.x
Subject(s) - medicine , incidence (geometry) , myasthenia gravis , pyridostigmine , population , confidence interval , pediatrics , demography , sociology , physics , environmental health , optics
Background An increase in late‐onset myasthenia gravis ( MG ) has been reported. There are few large population‐based studies over longer periods of time reflecting recent developments in MG incidence. Methods We identified a nationwide cohort of patients with incident myasthenia in D enmark in 1996–2009. We used a validated algorithm to track subjects based on a combination of diagnosis and prescription (pyridostigmine) data from nationwide registers. Patients with myasthenia were classified into early onset (<50 years old) and late onset (50+ years). We calculated incidence rates ( IR s) and corresponding 95% confidence intervals. Results We identified 693 patients (362 women) with incident MG in the study period corresponding to an IR of 9.2 per million person‐years (8.5–9.9). Overall, 207 (29.9%) were classified as early‐onset and 486 (70.1%) as late‐onset MG . Women predominated in the early‐onset group (70.5%), but not in the late‐onset group (44.4%). The incidence rate of early‐onset MG was 4.2 (3.6–4.8) and late‐onset MG 18.9 (17.3–20.7) per million person‐years and it did not vary over time in the study period ( P ‐values for trend 0.54 and 0.15, respectively). Conclusion Late‐onset MG comprised a large proportion of all incident cases in D enmark, was more common in men than women, and occurred with a stable incidence in the 14‐year study period. Therefore, we speculate whether previous reports of a rise in late‐onset MG reflect a non‐biological phenomenon, that is, a gradual improvement in the diagnosis of MG in this age group in previous years.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here